EP Patent

EP1521573A1 — Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use

Assigned to Alcon Inc · Expires 2005-04-13 · 21y expired

What this patent protects

Solid or semi-solid intraocular implant compositions are disclosed. The compositions contain a lipophilic compound but lack a polymeric ingredient.

USPTO Abstract

Solid or semi-solid intraocular implant compositions are disclosed. The compositions contain a lipophilic compound but lack a polymeric ingredient.

Drugs covered by this patent

Travatan (TRAVOPROST)

Patent Metadata

Patent number: EP1521573A1
Jurisdiction: EP
Classification: —
Expires: 2005-04-13
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.